BeiGene, Ltd. Insider Trading for July 2020
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in BeiGene, Ltd..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in BeiGene, Ltd. for July 2020.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 31 2020 | BGNE | BeiGene, Ltd. | Huang Jane | CMO, Hematology | Option Exercise | M | 12.34 | 19,500 | 240,630 | 212,680 | |
| Jul 31 2020 | BGNE | BeiGene, Ltd. | Huang Jane | CMO, Hematology | Option Exercise | M | 2.27 | 19,500 | 44,265 | 441,575 | |
| Jul 31 2020 | BGNE | BeiGene, Ltd. | Huang Jane | CMO, Hematology | Sell | S | 213.56 | 399 | 85,210 | 0 | 399 to 0 (-100.00 %) |
| Jul 31 2020 | BGNE | BeiGene, Ltd. | Huang Jane | CMO, Hematology | Sell | S | 212.53 | 400 | 85,011 | 399 | 799 to 399 (-50.06 %) |
| Jul 31 2020 | BGNE | BeiGene, Ltd. | Huang Jane | CMO, Hematology | Sell | S | 211.31 | 200 | 42,262 | 799 | 999 to 799 (-20.02 %) |
| Jul 31 2020 | BGNE | BeiGene, Ltd. | Huang Jane | CMO, Hematology | Sell | S | 208.91 | 700 | 146,237 | 999 | 1.7 K to 999 (-41.20 %) |
| Jul 31 2020 | BGNE | BeiGene, Ltd. | Huang Jane | CMO, Hematology | Sell | S | 208.35 | 1,301 | 271,067 | 1,699 | 3 K to 1.7 K (-43.37 %) |
| Jul 31 2020 | BGNE | BeiGene, Ltd. | Huang Jane | CMO, Hematology | Buy | M | 160.40 | 1,500 | 240,600 | 3,000 | 1.5 K to 3 K (+100.00 %) |
| Jul 31 2020 | BGNE | BeiGene, Ltd. | Huang Jane | CMO, Hematology | Buy | M | 29.49 | 1,500 | 44,235 | 1,500 | 0 to 1.5 K |
| Jul 22 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 248.00 | 100 | 24,800 | 0 | 100 to 0 (-100.00 %) |
| Jul 22 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 246.99 | 354 | 87,434 | 100 | 454 to 100 (-77.97 %) |
| Jul 22 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 245.78 | 146 | 35,884 | 454 | 600 to 454 (-24.33 %) |
| Jul 22 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 244.63 | 300 | 73,389 | 600 | 900 to 600 (-33.33 %) |
| Jul 22 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 243.36 | 1,000 | 243,355 | 900 | 1.9 K to 900 (-52.63 %) |
| Jul 22 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 242.62 | 1,900 | 460,985 | 1,900 | 3.8 K to 1.9 K (-50.00 %) |
| Jul 22 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 241.40 | 1,505 | 363,307 | 3,800 | 5.3 K to 3.8 K (-28.37 %) |
| Jul 22 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 240.27 | 1,795 | 431,284 | 5,305 | 7.1 K to 5.3 K (-25.28 %) |
| Jul 22 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 239.45 | 2,400 | 574,674 | 7,100 | 9.5 K to 7.1 K (-25.26 %) |
| Jul 22 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 238.54 | 3,300 | 787,182 | 9,500 | 12.8 K to 9.5 K (-25.78 %) |
| Jul 22 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 237.61 | 4,612 | 1,095,876 | 12,800 | 17.4 K to 12.8 K (-26.49 %) |
| Jul 22 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 236.14 | 4,200 | 991,788 | 17,412 | 21.6 K to 17.4 K (-19.43 %) |
| Jul 22 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 235.26 | 6,136 | 1,443,546 | 21,612 | 27.7 K to 21.6 K (-22.11 %) |
| Jul 22 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 255.53 | 1,300 | 332,195 | 0 | 1.3 K to 0 (-100.00 %) |
| Jul 22 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 254.29 | 3,594 | 913,914 | 1,300 | 4.9 K to 1.3 K (-73.44 %) |
| Jul 22 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 253.60 | 4,500 | 1,141,184 | 4,894 | 9.4 K to 4.9 K (-47.90 %) |
| Jul 22 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 252.34 | 3,896 | 983,119 | 9,394 | 13.3 K to 9.4 K (-29.32 %) |
| Jul 22 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 251.62 | 5,751 | 1,447,074 | 13,290 | 19 K to 13.3 K (-30.20 %) |
| Jul 22 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 250.49 | 1,612 | 403,790 | 19,041 | 20.7 K to 19 K (-7.81 %) |
| Jul 22 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 249.05 | 1,350 | 336,219 | 20,653 | 22 K to 20.7 K (-6.14 %) |
| Jul 22 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 248.12 | 4,410 | 1,094,201 | 22,003 | 26.4 K to 22 K (-16.70 %) |
| Jul 22 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 254.23 | 200 | 50,846 | 0 | 200 to 0 (-100.00 %) |
| Jul 22 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 253.67 | 6,948 | 1,762,528 | 200 | 7.1 K to 200 (-97.20 %) |
| Jul 22 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 252.56 | 7,345 | 1,855,061 | 7,148 | 14.5 K to 7.1 K (-50.68 %) |
| Jul 22 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 251.42 | 4,032 | 1,013,704 | 14,493 | 18.5 K to 14.5 K (-21.77 %) |
| Jul 22 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 250.51 | 7,326 | 1,835,211 | 18,525 | 25.9 K to 18.5 K (-28.34 %) |
| Jul 22 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 249.82 | 2,211 | 552,345 | 25,851 | 28.1 K to 25.9 K (-7.88 %) |
| Jul 22 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 248.70 | 700 | 174,088 | 28,062 | 28.8 K to 28.1 K (-2.43 %) |
| Jul 22 2020 | BGNE | BeiGene, Ltd. | Wang Xiaodong | Director | Sell | S | 253.59 | 1,379 | 349,703 | 0 | 1.4 K to 0 (-100.00 %) |
| Jul 22 2020 | BGNE | BeiGene, Ltd. | Wang Xiaodong | Director | Sell | S | 252.61 | 2,039 | 515,075 | 1,379 | 3.4 K to 1.4 K (-59.65 %) |
| Jul 22 2020 | BGNE | BeiGene, Ltd. | Wang Xiaodong | Director | Sell | S | 251.31 | 2,652 | 666,470 | 3,418 | 6.1 K to 3.4 K (-43.69 %) |
| Jul 22 2020 | BGNE | BeiGene, Ltd. | Wang Xiaodong | Director | Sell | S | 250.39 | 5,430 | 1,359,602 | 6,070 | 11.5 K to 6.1 K (-47.22 %) |
| Jul 22 2020 | BGNE | BeiGene, Ltd. | Wang Xiaodong | Director | Sell | S | 249.78 | 500 | 124,890 | 11,500 | 12 K to 11.5 K (-4.17 %) |
| Jul 22 2020 | BGNE | BeiGene, Ltd. | Wang Xiaodong | Director | Sell | S | 253.49 | 1,111 | 281,632 | 0 | 1.1 K to 0 (-100.00 %) |
| Jul 22 2020 | BGNE | BeiGene, Ltd. | Wang Xiaodong | Director | Sell | S | 252.57 | 1,902 | 480,383 | 1,111 | 3 K to 1.1 K (-63.13 %) |
| Jul 22 2020 | BGNE | BeiGene, Ltd. | Wang Xiaodong | Director | Sell | S | 251.34 | 687 | 172,668 | 3,013 | 3.7 K to 3 K (-18.57 %) |
| Jul 22 2020 | BGNE | BeiGene, Ltd. | Wang Xiaodong | Director | Sell | S | 250.33 | 1,000 | 250,332 | 3,700 | 4.7 K to 3.7 K (-21.28 %) |
| Jul 22 2020 | BGNE | BeiGene, Ltd. | Wang Xiaodong | Director | Sell | S | 249.60 | 300 | 74,881 | 4,700 | 5 K to 4.7 K (-6.00 %) |
| Jul 22 2020 | BGNE | BeiGene, Ltd. | Wang Xiaodong | Director | Sell | S | 253.59 | 1,379 | 349,703 | 0 | 1.4 K to 0 (-100.00 %) |
| Jul 22 2020 | BGNE | BeiGene, Ltd. | Wang Xiaodong | Director | Sell | S | 252.61 | 2,039 | 515,075 | 1,379 | 3.4 K to 1.4 K (-59.65 %) |
| Jul 22 2020 | BGNE | BeiGene, Ltd. | Wang Xiaodong | Director | Sell | S | 251.31 | 2,652 | 666,470 | 3,418 | 6.1 K to 3.4 K (-43.69 %) |
| Jul 22 2020 | BGNE | BeiGene, Ltd. | Wang Xiaodong | Director | Sell | S | 250.39 | 5,430 | 1,359,602 | 6,070 | 11.5 K to 6.1 K (-47.22 %) |
| Jul 22 2020 | BGNE | BeiGene, Ltd. | Wang Xiaodong | Director | Sell | S | 249.78 | 500 | 124,890 | 11,500 | 12 K to 11.5 K (-4.17 %) |
| Jul 22 2020 | BGNE | BeiGene, Ltd. | Wang Xiaodong | Director | Sell | S | 253.49 | 1,111 | 281,632 | 0 | 1.1 K to 0 (-100.00 %) |
| Jul 22 2020 | BGNE | BeiGene, Ltd. | Wang Xiaodong | Director | Sell | S | 252.57 | 1,902 | 480,383 | 1,111 | 3 K to 1.1 K (-63.13 %) |
| Jul 22 2020 | BGNE | BeiGene, Ltd. | Wang Xiaodong | Director | Sell | S | 251.34 | 687 | 172,668 | 3,013 | 3.7 K to 3 K (-18.57 %) |
| Jul 22 2020 | BGNE | BeiGene, Ltd. | Wang Xiaodong | Director | Sell | S | 250.33 | 1,000 | 250,332 | 3,700 | 4.7 K to 3.7 K (-21.28 %) |
| Jul 22 2020 | BGNE | BeiGene, Ltd. | Wang Xiaodong | Director | Sell | S | 249.60 | 300 | 74,881 | 4,700 | 5 K to 4.7 K (-6.00 %) |
| Jul 21 2020 | BGNE | BeiGene, Ltd. | Wu Xiaobin | President & GM Chin ... | Sell | S | 250.16 | 2,600 | 650,407 | 0 | 2.6 K to 0 (-100.00 %) |
| Jul 21 2020 | BGNE | BeiGene, Ltd. | Wu Xiaobin | President & GM Chin ... | Sell | S | 250.04 | 400 | 100,015 | 0 | 400 to 0 (-100.00 %) |
| Jul 21 2020 | BGNE | BeiGene, Ltd. | Wu Xiaobin | President & GM Chin ... | Sell | S | 240.00 | 300 | 72,000 | 400 | 700 to 400 (-42.86 %) |
| Jul 17 2020 | BGNE | BeiGene, Ltd. | BAKER BROS. ADVISORS LP | Director | Grant | A | 14.23 | 13,589,904 | 193,395,206 | 18,840,379 | 5.3 M to 18.8 M (+258.83 %) |
| Jul 17 2020 | BGNE | BeiGene, Ltd. | BAKER BROS. ADVISORS LP | Director | Grant | A | 14.23 | 994,276 | 14,149,343 | 1,021,851 | 27.6 K to 1 M (+3,605.72 %) |
| Jul 16 2020 | BGNE | BeiGene, Ltd. | AMGEN INC | 10% Owner | Grant | A | 14.23 | 29,614,832 | 421,442,751 | 236,249,845 | 206.6 M to 236.2 M (+14.33 %) |
| Jul 15 2020 | BGNE | BeiGene, Ltd. | Wu Xiaobin | President & GM Chin ... | Sell | S | 246.10 | 200 | 49,220 | 0 | 200 to 0 (-100.00 %) |
| Jul 15 2020 | BGNE | BeiGene, Ltd. | Wu Xiaobin | President & GM Chin ... | Sell | S | 243.91 | 200 | 48,781 | 200 | 400 to 200 (-50.00 %) |
| Jul 15 2020 | BGNE | BeiGene, Ltd. | Wu Xiaobin | President & GM Chin ... | Sell | S | 242.63 | 300 | 72,789 | 400 | 700 to 400 (-42.86 %) |
| Jul 15 2020 | BGNE | BeiGene, Ltd. | Wu Xiaobin | President & GM Chin ... | Sell | S | 240.10 | 2,000 | 480,208 | 700 | 2.7 K to 700 (-74.07 %) |
| Jul 15 2020 | BGNE | BeiGene, Ltd. | Wu Xiaobin | President & GM Chin ... | Sell | S | 220.00 | 3,000 | 660,000 | 0 | 3 K to 0 (-100.00 %) |
| Jul 09 2020 | BGNE | BeiGene, Ltd. | Wang Xiaodong | Director | Sell | S | 200.00 | 6,000 | 1,200,000 | 0 | 6 K to 0 (-100.00 %) |
| Jul 09 2020 | BGNE | BeiGene, Ltd. | Huang Jane | CMO, Hematology | Option Exercise | M | 12.34 | 50,973 | 629,007 | 232,180 | |
| Jul 09 2020 | BGNE | BeiGene, Ltd. | Huang Jane | CMO, Hematology | Sell | S | 200.00 | 3,921 | 784,200 | 0 | 3.9 K to 0 (-100.00 %) |
| Jul 09 2020 | BGNE | BeiGene, Ltd. | Huang Jane | CMO, Hematology | Buy | M | 160.40 | 3,921 | 628,928 | 3,921 | 0 to 3.9 K |
| Jul 08 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 203.81 | 2,854 | 581,680 | 0 | 2.9 K to 0 (-100.00 %) |
| Jul 08 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 202.37 | 3,834 | 775,895 | 2,854 | 6.7 K to 2.9 K (-57.33 %) |
| Jul 08 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 201.58 | 4,841 | 975,869 | 6,688 | 11.5 K to 6.7 K (-41.99 %) |
| Jul 08 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 200.55 | 2,900 | 581,597 | 11,529 | 14.4 K to 11.5 K (-20.10 %) |
| Jul 08 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 199.26 | 1,800 | 358,672 | 14,429 | 16.2 K to 14.4 K (-11.09 %) |
| Jul 08 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 197.98 | 700 | 138,585 | 16,229 | 16.9 K to 16.2 K (-4.13 %) |
| Jul 08 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 196.51 | 600 | 117,908 | 16,929 | 17.5 K to 16.9 K (-3.42 %) |
| Jul 08 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 199.88 | 8,318 | 1,662,567 | 0 | 8.3 K to 0 (-100.00 %) |
| Jul 08 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 199.01 | 5,474 | 1,089,391 | 8,318 | 13.8 K to 8.3 K (-39.69 %) |
| Jul 08 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 197.80 | 1,501 | 296,903 | 13,792 | 15.3 K to 13.8 K (-9.81 %) |
| Jul 08 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 196.82 | 3,730 | 734,126 | 15,293 | 19 K to 15.3 K (-19.61 %) |
| Jul 08 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 198.32 | 2,561 | 507,901 | 0 | 2.6 K to 0 (-100.00 %) |
| Jul 08 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 197.43 | 6,300 | 1,243,810 | 2,561 | 8.9 K to 2.6 K (-71.10 %) |
| Jul 08 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 196.62 | 7,701 | 1,514,204 | 8,861 | 16.6 K to 8.9 K (-46.50 %) |
| Jul 08 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 195.43 | 800 | 156,347 | 16,562 | 17.4 K to 16.6 K (-4.61 %) |
| Jul 06 2020 | BGNE | BeiGene, Ltd. | Wang Xiaodong | Director | Sell | S | 192.31 | 457 | 87,887 | 0 | 457 to 0 (-100.00 %) |
| Jul 06 2020 | BGNE | BeiGene, Ltd. | Wang Xiaodong | Director | Sell | S | 191.37 | 1,600 | 306,184 | 457 | 2.1 K to 457 (-77.78 %) |
| Jul 06 2020 | BGNE | BeiGene, Ltd. | Wang Xiaodong | Director | Sell | S | 190.46 | 2,100 | 399,957 | 2,057 | 4.2 K to 2.1 K (-50.52 %) |
| Jul 06 2020 | BGNE | BeiGene, Ltd. | Wang Xiaodong | Director | Sell | S | 189.19 | 690 | 130,544 | 4,157 | 4.8 K to 4.2 K (-14.24 %) |
| Jul 06 2020 | BGNE | BeiGene, Ltd. | Wang Xiaodong | Director | Sell | S | 192.31 | 457 | 87,887 | 0 | 457 to 0 (-100.00 %) |
| Jul 06 2020 | BGNE | BeiGene, Ltd. | Wang Xiaodong | Director | Sell | S | 191.37 | 1,600 | 306,184 | 457 | 2.1 K to 457 (-77.78 %) |
| Jul 06 2020 | BGNE | BeiGene, Ltd. | Wang Xiaodong | Director | Sell | S | 190.46 | 2,100 | 399,957 | 2,057 | 4.2 K to 2.1 K (-50.52 %) |
| Jul 06 2020 | BGNE | BeiGene, Ltd. | Wang Xiaodong | Director | Sell | S | 189.19 | 690 | 130,544 | 4,157 | 4.8 K to 4.2 K (-14.24 %) |
| Jul 01 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 192.08 | 1,800 | 345,752 | 0 | 1.8 K to 0 (-100.00 %) |
| Jul 01 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 191.10 | 2,016 | 385,265 | 1,800 | 3.8 K to 1.8 K (-52.83 %) |
| Jul 01 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 193.68 | 35 | 6,779 | 0 | 35 to 0 (-100.00 %) |
| Jul 01 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 192.84 | 1,100 | 212,128 | 35 | 1.1 K to 35 (-96.92 %) |
| Jul 01 2020 | BGNE | BeiGene, Ltd. | OYLER JOHN | Chief Executive Off ... | Sell | S | 191.56 | 300 | 57,468 | 1,135 | 1.4 K to 1.1 K (-20.91 %) |
| Jul 01 2020 | BGNE | BeiGene, Ltd. | Liang Howard | CFO & Chief Strateg ... | Sell | S | 191.23 | 300 | 57,368 | 0 | 300 to 0 (-100.00 %) |